Cerus reported $24.52M in Gross Profit on Sales for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Atrion ATRI:US 17.79M 77K
Cerus CERS:US $ 24.52M 2.08M
GRIFOLS GRF:SM € 580.8M 47.47M
Haemonetics HAE:US $ 122.75M 12.41M
Meridian Bioscience VIVO:US $ 44.72M 7.61M
Neogen NEOG:US $ 60.01M 2.32M
Nuvasive NUVA:US $ 182.18M 34.36M
Orasure Technologies OSUR:US $ 21.47M 9.2M
Quidel QDEL:US $ 373.41M 267.22M
Rockwell Medical RMTI:US $ -0.33M 0.07M
Sientra SIEN:US 10.59M 675K
Staar Surgical STAA:US $ 45.3M 3.9M
Terumo 4543:JP Y 91985M 2274M